Win a free GPS from Gadling!

AOL Money & Finance

Option Update: Celgene volatility at low end of range into positive data

Celgene (NASDAQ: CELG), a biopharmaceutical company with a market cap of $$26 billion, was up $1.51 to $60.80 in pre-open trading.

Cowen says "ECOG Revlimid Study-Interesting Post Hoc Analysis Shows Promising Survival rates With Long-Term Use in The Elderly."

CELG over all option implied volatility of 39 is below its 26-week average of 43 according to Track Data, suggesting decreasing price risk.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Related Posts

Add your comments

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.

New Users

Current Users

Symbol Lookup
IndexesChangePrice
DJIA-283.1011,349.28
NASDAQ-45.772,280.11
S&P 500-29.651,252.54

Last updated: July 24, 2008: 05:43 PM

BloggingStocks Exclusives

Hot Stocks

BloggingStocks Featured Video

TheFlyOnTheWall.com Headlines

WalletPop Headlines

    AOL Business News

    Latest from BloggingBuyouts

    Sponsored Links

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.